Alyve Medical Announces New Headquarters and Launch of Rental Program for Neuralign S @Home

DENVER--()--Alyve Medical Inc., a global medical technology company and leader in data-driven joint kinematics tools and personalized neuromuscular electrical stimulation (NMES) technologies, has announced the opening of their new global company headquarters. In concert with the growth of the company and the commercial traction in the U.S. and around the globe, Alyve Medical secured space in the Cherry Creek Plaza I tower in Denver, Colorado. Occupancy of the new office began in mid-December 2022.

In addition, the company is excited to announce the U.S. launch of a remote, in-home option for treatment with Neuralign System™ S. Using the FDA-cleared Neuralign S @Home version of the device, patients can augment any in-clinic physical therapy through daily treatment sessions with Neuralign’s patented Motion Activated Stimulation (MAS) technology in the comfort and convenience of their own home. Upon prescription by a physician, patients can rent a Neuralign S @Home device on a monthly basis through the course of their treatment. Healthcare providers with a Neuralign S Pro version of the device in their clinic are able to remotely monitor the patient's progress and compliance with therapy as well as customize the treatment protocols on the patient’s device. Both patients and providers had been requesting this service and a steady increase in rental activity is already being realized.

“To be able to expand our service offering and meet both patient and provider needs is very rewarding. Providing options for remote utilization of Neuralign S, and to launch the program exactly in the timeframe we had anticipated demonstrates the team’s strong execution” said Yvonne Bokelman, Chief Executive Officer. “We look forward to continuing to demonstrate our mission of changing the paradigm of musculoskeletal care.”

About Alyve Medical

Alyve Medical Inc., is a novel medical technology company focused on reimagining the management of musculoskeletal care. Through NCS Lab srl (Carpi, Italy), they have developed two FDA-approved innovative and novel platforms that used together or individually, aid clinicians in diagnosing, treating and preventing musculoskeletal injuries. These non-invasive technologies, deployed in physician offices and physical therapy clinics today are being used to observe normal and abnormal joint function in orthopedic treatments, physical therapy delivery, and athletic performance. Multiple studies are in progress validating and confirming this transformation in the way human movements are evaluated, measured and rehabilitated. For more information, please visit https://alyvemedical.com/

Contacts

Media & Investor Relations
Sean D. Murphy
smurphy@alyvemedical.com
(303) 381-0375
https://alyvemedical.com/

Contacts

Media & Investor Relations
Sean D. Murphy
smurphy@alyvemedical.com
(303) 381-0375
https://alyvemedical.com/